John C Reed insider trades

Open-market stock purchases and sales by John C Reed, Director at Madrigal Pharmaceuticals, Inc, from SEC Form 4 filings since Jul 1, 2010.

Recent trades

DateStockTradeValue
Aug 15, 2026MDGL Madrigal Pharmaceuticals, IncBought (not open market)—
Aug 15, 2026MDGL Madrigal Pharmaceuticals, IncBought (not open market)—
May 1, 2026JNJ Johnson & JohnsonSold (not open market)$2.5M
May 1, 2026JNJ Johnson & JohnsonBought (not open market)—
Feb 17, 2026JNJ Johnson & JohnsonSold$5.3M
Feb 17, 2026JNJ Johnson & JohnsonBought (not open market)—
Feb 17, 2026JNJ Johnson & JohnsonBought (not open market)—
Feb 17, 2026JNJ Johnson & JohnsonSold$7.3M
Feb 17, 2026JNJ Johnson & JohnsonSold$555K
Feb 15, 2026JNJ Johnson & JohnsonSold (not open market)$93.7K
Feb 15, 2026JNJ Johnson & JohnsonSold (not open market)$129K
Feb 15, 2026JNJ Johnson & JohnsonBought (not open market)—
Feb 15, 2026JNJ Johnson & JohnsonBought (not open market)—
Feb 15, 2026JNJ Johnson & JohnsonBought (not open market)—
Feb 15, 2026JNJ Johnson & JohnsonBought (not open market)—

Companies traded

  • MDGL Madrigal Pharmaceuticals, Inc: other filings, last Aug 15, 2026
  • JNJ Johnson & Johnson: 5 sales, last May 1, 2026
  • ISIS Isis Pharmaceuticals Inc: 4 sales, last Sep 6, 2012
  • CLVS Clovis Oncology, Inc: other filings, last Jun 14, 2012

Get free alerts when John C Reed files a new trade →